Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | SFL’s Managing Director Invited to Speak at DIA 49th Annual Meeting in BostonSFL to attend the DIA 49th Annual Meeting (Booth 1744) in Boston June 23-27, 2013.
Ms. Fürst-Ladani has been invited to speak at the session “Co-development of Targeted Therapies and Companion Diagnostics: “This session will assist manufacturers in understanding the regulatory changes taking place for CDxs,” commented Shayesteh. “It will enable companies to learn about the practical implications of the new regulatory framework and understand what will be expected of them in the future in terms of meeting required standards. Shayesteh is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug and device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products. Shayesteh is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012, 2013 and 2014 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. In 2012 she received the Open University Business School’s Alumni Award Outstanding Contribution to an Organization. SFL will be at Booth 1744 during the DIA 49th Annual Meeting in Boston June 23-27, 2013. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|